Prosecution Insights
Last updated: November 20, 2026
Application No. 19/044,256

TISSUE ABLATION DEVICE WITH NERVE STIMULATION FEATURE

Non-Final OA §102§103
Filed
Feb 03, 2025
Priority
Feb 12, 2024 — provisional 63/552,229
Examiner
SHOULDERS, ANNIE LEE
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medtronic Xomed, LLC
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
1y 9m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
163 granted / 218 resolved
+4.8% vs TC avg
Strong +18% interview lift
Without
With
+18.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
34 currently pending
Career history
265
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
58.1%
+18.1% vs TC avg
§102
18.9%
-21.1% vs TC avg
§112
15.8%
-24.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 218 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status 1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . 2. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Rejections - 35 USC § 102 3. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. 4. Claim 4 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Johnson U.S. 2024/0423687 (herein referred to as “Johnson”). 5. Regarding Claim 4, Johnson teaches an ablation device (Fig. 2, ref num 200, 204, 206), comprising: a. an elongated shaft (Fig. 2, ref num 114) extending distally from a handle (Fig. 2, ref num 116); b. a stimulation electrode disposed on a distal tip portion of the elongated shaft (Fig. 2, ref num 212), the stimulation electrode configured to electrically stimulate nerves (para 0054, “the values for the delivery parameters described above are selected based on one or more factors such as, for example, efficacy, treatment duration, treatment outcomes, patient pain, damage to tissues other than the SI joint, tissue heating, generation of bubbles in body fluids, skeletal muscle stimulation, arcing, tissue aggregation, or the like or any combination thereof”; also see para 0029); c. an ablation electrode disposed on the elongated shaft and axially spaced proximally from the stimulation electrode (Fig. 2, ref num 213; para 0037-0038), the ablation electrode configured to deliver electrosurgical energy to tissue (para 0037-0038); and d. an insulative ring surrounding the elongated shaft and disposed between the stimulation electrode and the ablation electrode (Fig. 2, ref num 215; para 0037, “Each adjacent pair of electrode elements of a multipolar ablation electrode 204 is separated by insulative material 215”). 6. Claims 5 and 6 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Sharkey U.S. 5,954,716 (herein referred to as “Sharkey”). 7. Regarding Claim 5, Sharkey teaches an ablation device (Fig. 1), comprising: a. an elongated shaft extending distally from a handle (Fig. 1, ref num 14 extends from ref num 12); b. an electrode disposed on a distal portion of the elongated shaft (Fig. 1, ref num 20; Col. 8, lines 56-57, “distal portion 20 with an electrode or other energy delivery device”) and configured to deliver electrosurgical energy to tissue (Col. 7, lines 61-63); and c. a retractable sleeve disposed on the elongated shaft and configured to be moved along the elongated shaft relative to the electrode to adjust a surface area of the electrode that is exposed during delivery of the electrosurgical energy to the tissue (Col. 9, lines 9-15, “The area of the energy delivery device (e.g., electrode) that serves as a conductive surface can be adjusted by the inclusion of an insulating sleeve that is positioned around the energy delivery device. The sleeve may be advanced and retracted along the surface of the energy delivery device in order to increase or decrease the surface area of conductive surface that is directed to collagen containing ligament 28”). 8. Regarding Claim 6, Sharkey teaches the electrode is monopolar (Col. 9, lines 50-51, “A monopolar electrode is a part of a circuit that includes the RF signal generator”). Claim Rejections - 35 USC § 103 9. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. 10. Claims 1 and 3 are rejected under 35 U.S.C. 103 as being unpatentable over Johnson and in view of Crosby U.S. 2025/0001164 (herein referred to as “Crosby”). 11. Regarding Claim 1, Johnson U.S. 2024/0423687 teaches an ablation system (Fig. 2, ref num 200), comprising: an ablation device configured to be inserted into an ablation target (Fig. 2, ref nums 204, 206), the ablation device including: a. an elongated shaft (Fig. 2, ref num 114) extending distally from a handle (Fig. 2, ref num 116); b. a stimulation electrode disposed on a distal tip portion of the elongated shaft (Fig. 2, ref num 212), the stimulation electrode configured to electrically stimulate nerves (para 0054, “the values for the delivery parameters described above are selected based on one or more factors such as, for example, efficacy, treatment duration, treatment outcomes, patient pain, damage to tissues other than the SI joint, tissue heating, generation of bubbles in body fluids, skeletal muscle stimulation, arcing, tissue aggregation, or the like or any combination thereof”; also see para 0029); c. an ablation electrode disposed on the elongated shaft and axially spaced proximally from the stimulation electrode (Fig. 2, ref num 213; para 0037-0038), the ablation electrode configured to deliver electrosurgical energy to tissue (para 0037-0038); and d. an insulative ring surrounding the elongated shaft and disposed between the stimulation electrode and the ablation electrode (Fig. 2, ref num 215; para 0037, “Each adjacent pair of electrode elements of a multipolar ablation electrode 204 is separated by insulative material 215”); and an electrosurgical generator configured to deliver electrosurgical energy to the ablation electrode of the ablation device (Fig. 2, ref num 102). Johnson fails to teach a nerve monitoring unit configured to deliver electrical stimulation signals to the stimulation electrode of the ablation device. Crosby teaches an ablation system of analogous art (Fig. 7), wherein the system comprises a nerve monitoring unit configured to deliver electrical stimulation signals to a stimulation electrode to the nerve monitoring unit (para 0124-0125). By monitoring the electrical stimulation signals, this allows the user to adjust the electrical stimulation signals to selectively stimulate the nerves (para 0031, 0060). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Johnson to include a nerve monitoring unit to selectively stimulate the nerve. 12. Regarding Claim 3, Johnson fails to teach the electrosurgical generator and the nerve monitoring unit are disposed within a common enclosure. Crosby teaches the electrosurgical generator and nerve monitoring unit are disposed within a common enclosure (Fig. 7, ref num 91 and 89 are within common enclosure 80). This produces the same expected result of controlling the ablation and stimulation parameters of the system (para 0125-0126). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Johnson to have the generator and nerve monitoring unit disposed within a common enclosure, as this is a well-known modification in the art, and produces the same expected result. 13. Claim 2 is rejected under 35 U.S.C. 103 as being unpatentable over Johnson and Crosby, and further in view of Schepis U.S. 2020/0038096 (herein referred to as “Schepis”). 14. Regarding Claim 2, Johnson fails to teach a patient interface unit electrically coupleable to the nerve monitoring unit and configured to electrically couple the stimulation electrode to the nerve monitoring unit. Schepis teaches an ablation system of analogous art (Fig. 4), wherein the system comprises a patient interface unit (Fig. 4, ref num 140; para 0079) that is electrically coupleable to a nerve monitoring unit (Fig. 4, ref num 140 is electrically coupled to ref num 130 via ref num 150) and configured to couple the stimulation electrode (see Fig. 4, ref num 16) to the nerve monitoring unit (para 0117). This provides control over the entire system and stimulation of the nerves (para 0117). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Johnson to have included a patient interface unit that is electrically coupled to the nerve monitoring unit to control the stimulation of the nerves. Conclusion 15. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANNIE L SHOULDERS whose telephone number is (571)272-3846. The examiner can normally be reached Monday-Friday (alternate Fridays) 8AM-5PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Stoklosa can be reached at 571-272-1213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANNIE L SHOULDERS/Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Feb 03, 2025
Application Filed
Sep 01, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702473
SYSTEMS FOR IMPROVING THE APPEARANCE OF TISSUE
4y 0m to grant Granted Aug 11, 2026
Patent 12702476
FORCE SENSING CATHETER INCLUDING SEALED ELECTRODE TIP ASSEMBLY AND METHODS OF ASSEMBLING SAME
2y 2m to grant Granted Aug 11, 2026
Patent 12678223
SYSTEMS AND METHODS FOR CYLINDRICAL CAGE MAPPING AND ABLATION CATHETERS HAVING FLEXIBLE CIRCUITS
2y 8m to grant Granted Jul 14, 2026
Patent 12678327
CAPSULOTOMY DEVICE
2y 7m to grant Granted Jul 14, 2026
Patent 12643111
NANO SURFACES ON SMOKE PARTICLE ELECTRODES
3y 7m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
93%
With Interview (+18.2%)
3y 6m (~1y 9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 218 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month